Approvals/TGA/ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack

Approved

STANDARD

ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack

Lupin Australia Pty Limited🇦🇺 Therapeutic Goods Administration

Approval Id: efe2c116579aa2b8
Product Name: ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack
Artg Id: 281022
Artg Name: ABACAVIR/LAMIVUDINE LUPIN 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack
Sponsor: Lupin Australia Pty Limited
Company Detail Path: /organization/lupin-australia-pty-limited
Artg Date: 2017-10-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

efe2c116579aa2b8

Type

Standard